Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Mood disturbance and pregnancy: pros and cons of pharmacologic treatment

Full text
Author(s):
Claudio N Soares [1] ; Adele C Viguera [2] ; Lee S Cohen [3]
Total Authors: 3
Affiliation:
[1] Harvard Medical School. Department of Psychiatry. Massachusetts General Hospital - Estados Unidos
[2] Harvard Medical School. Department of Psychiatry. Massachusetts General Hospital - Estados Unidos
[3] Harvard Medical School. Department of Psychiatry. Massachusetts General Hospital - Estados Unidos
Total Affiliations: 3
Document type: Journal article
Source: Revista Brasileira de Psiquiatria; v. 23, n. 1, p. 48-53, 2001-03-00.
Abstract

The management of psychiatric disturbances during pregnancy, particularly depression and bipolar disorders, is complex. This article reviews the existing data regarding the impact of an untreated psychiatric illness on the infant's development. In addition, the potential risks to the fetus due to prenatal exposure to different psychotropic agents, including antidepressants, mood stabilizers, antipsychotics, and benzodiazepines, are summarized. Moreover, this article emphasizes that no decision is risk-free, and the ultimate goal is to reduce the exposure to both the illness and the potential teratogenic effects of the treatment. Therefore, clinicians should seek a treatment strategy, which poses the least risk for both mother and infant. (AU)